Nerve Pain study: Ultrasound Guided Approach
Official title Ultrasound Guided Radiofrequency Ablation of the Occipital Nerve
ClinicalTrials.gov ID: NCT06583122
What this study is testing
- What it's testing
- The study wants to find out if using ultrasound to see the needle during the procedure reduces pain after the usual treatment.
- Who it's for
- Adults who have occipital nerve pain.
- What's involved
- You will have an ultrasound‑guided radiofrequency ablation of the occipital nerve, which involves a needle placed under imaging, plus any standard follow‑up checks.
- Time commitment
- One treatment session with a few follow‑up visits afterward.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Patients between the ages of 18-80 with a diagnosis of occipital neuralgia or migraine overlying the occipital region.
- A diagnosis of occipital neuralgia will be based on the International Classification of Headache Disorders (ICHD), whose criteria include: paroxysmal...
- Patients may also be included if they have a diagnosis of migraine based on the ICHD criteria with predominance of pain over the occipital region...
- Patients must have failed oral medications including NSAIDs, opioids, and anticonvulsants for the management of their pain.
- Failed treatment will be \<50% pain reduction with oral medication.
You likely can't join if
- Patients will be excluded from the trial if they have an unstable medical or psychological condition,
- are pregnant,
- have an implanted cardiac pacemaker or defibrillator that could not be disabled,
- have had a craniotomy or scar tissue overlying the site from a previous surgery,
- have a history of cervical spine fusion,
- have evidence of elevated ICP or intracranial tumor,
See the full eligibility criteria
- Patients between the ages of 18-80 with a diagnosis of occipital neuralgia or migraine overlying the occipital region.
- A diagnosis of occipital neuralgia will be based on the International Classification of Headache Disorders (ICHD), whose criteria include: paroxysmal stabbing pain in the distribution of the GON, tenderness over the...
- Patients may also be included if they have a diagnosis of migraine based on the ICHD criteria with predominance of pain over the occipital region that responded to occipital nerve block.
- Patients must have failed oral medications including NSAIDs, opioids, and anticonvulsants for the management of their pain.
- Failed treatment will be \<50% pain reduction with oral medication.
- Patients must report headache frequency of at least 10 days per month.
- Patients will be excluded from the trial if they have an unstable medical or psychological condition,
- are pregnant,
- have an implanted cardiac pacemaker or defibrillator that could not be disabled,
- have had a craniotomy or scar tissue overlying the site from a previous surgery,
- have a history of cervical spine fusion,
- have evidence of elevated ICP or intracranial tumor,
- or have previous RFA treatment of the greater or lesser occipital nerve.
The study team makes the final eligibility decision.
Where it is enrolling
- Kansas City, Kansas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Kansas City, Kansas, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.